Skip to main content

Table 2 Survival status by risk factors among new smear-positive tuberculosis patients

From: High mortality during tuberculosis treatment does not indicate long diagnostic delays in Vietnam: a cohort study

 

Survival N

Death N (%)

P value

Crude OR (95%CI)

Adjusted* OR (95%CI)

All (n = 1,881)

1799

82 (4.4%)

   

Diagnostic Delay

  

0.42

  

   Continuous†, per Ln(delay-week)

1799

82 (4.4%)

 

0.77 (0.57–1.03)

0.78 (0.58–1.05)

   ≤ 4 weeks

931

44 (4.5%)

 

1

1

   5- ≤ 8 weeks

479

25 (5.0%)

 

1.10 (0.67–1.83)

1.11 (0.67–1.84)

   > 9 weeks

389

13 (3.2%)

 

0.71 (0.38–1.33)

0.69 (0.37–1.30)

Sex

  

0.138

  

   Men

1262

64 (4.8%)

 

1

1

   Women

537

18 (3.2%)

 

0.66 (0.39–1.13)

0.58 (0.34–1.00)

Age, years

  

0.010

  

   15–34

470

20 (4.1%)

 

1

1

   35–54

731

22 (2.9%)

 

0.71 (0.38–1.31)

0.68 (0.37–1.27)

   ≥ 55

598

40 (6.3%)

 

1.57 (0.91–2.7)

1.64 (0.37–1.27)

Sputum grade at diagnosis (n = 1,827)

  

0.256

  

   Scanty

119

10 (7.8%)

 

2.1 (1.01–4.2)

2.1 (1.02–4.3)

   1+

1028

42 (3.9%)

 

1

1

   2+

370

18 (4.6%)

 

1.19 (0.68–2.1)

1.22 (0.69–2.2)

   3+

230

7 (4.2%)

 

1.06 (0.53–2.2)

1.14 (0.56–2.3)

  1. * Adjusted for age group, diagnostic delay and sex
  2. OR = Odds Ratio
  3. † Log transformation